Healthcare Industry News: B. Braun
News Release - January 16, 2008
Aesculap Awarded Wound Closure Agreement with Amerinet, National GPO
Agreement Offers Significant Costs Savings to Sutures & Tissue Adhesive ProductsST. LOUIS--(HSMN NewsFeed)--Aesculap announced today that is has been awarded supplier agreements with Amerinet, a national health care group purchasing organization. The two agreements, effective February 1, 2008 through January 31, 2011, provides Amerinet’s more than 2,000 acute care members access to Aesculap’s high-quality sutures and Histoacryl™ tissue adhesive products.
While a supplier on the previous contract for sutures, this new contract extends to Amerinet members access to one of Aesculap’s latest wound closure products - - - Histoacryl tissue adhesive. Approved by the FDA for sale in the United States in February 2007, Histoacryl and Histoacryl Blue are two versions of the topical skin adhesive that has been widely-used in Europe and the rest of the world,
Unlike other products in this category, Histoacryl is the only skin adhesive available in both optically clear and blue formulations. Both formulations polymerize in seconds, require only a single-layer application, and provide one of the highest bond strength of all FDA-approved topical skin adhesives. As a result, surgeons are able to close wounds and incisions with a precise, single-application adhesive that offers great cosmetic results as well as faster application without compromising the strength of the wound closure.
"Aesculap has a long history of delivering exceptional products and value to our members,” stated Gene Byerly, Amerinet vice president of medical surgical. “We are excited to have Aesculap as a partner for these wound closure products. This agreement demonstrates Aesculap’s ongoing commitment to providing Amerinet members with high-quality products that provide both clinical benefit and cost saving opportunities.”
Histoacryl is manufactured by B. Braun and has been marketing outside the United States for more than 30 years. In the United States, Histoacryl is distributed by the Aesculap subsidiary of B. Braun in partnership with TissueSeal LLC. Histoacryl has been cited in more than 1000 articles in clinical publications worldwide.
About Amerinet Inc.
Through Total Spend Management solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members’ specific needs.
Based in St. Louis, with offices in Salt Lake City, Providence, R.I., and Pittsburgh, Amerinet serves more than 25,000 acute and non-acute health care providers nationwide. To learn more, visit www.amerinet-gpo.com.
About B. Braun / Aesculap
B. Braun is the recipient of the 2007 Frost & Sullivan Medical Technology Global Excellence Award for its excellence in helping healthcare providers improve the lives of their patients. Since its founding in 1839, B. Braun has built an unparalleled store of knowledge and expertise in delivering innovative healthcare products, medical devices and programs that enhance working processes in hospitals, alternate care settings and medical practices. B. Braun’s Aesculap division focuses on products and services for core processes in surgery. The product range includes among other items surgical instruments for open or minimally invasive approaches, implants (e.g. for orthopaedics, neurosurgery and spinal surgery), surgical sutures, topical skin adhesive, sterile container, storage, motor and navigation systems as well as products for cardiology.
The company’s more than 34,000 employees worldwide are proud of their commitment to translating customer needs into products with unmatched quality, superior technology, cost-effectiveness and environmental responsibility. Through its "Sharing Expertise®" initiative, B. Braun promotes best practices for continuous improvement of healthcare products and services.
Histoacryl is a trademark of B. Braun Melsungen AG
About TissueSeal LLC
TissueSeal headquartered in Ann Arbor, Michigan was founded in 2003 and is a provider of medical/surgical products in the United States. TissueSeal, in collaboration with B. Braun and its U.S. subsidiary Aesculap, achieved regulatory approval in February 2007 for the sale and distribution of its Histoacryl topical skin adhesive.
With the introduction of Histoacryl to the U.S. market, TissueSeal is able to offer an outstanding, proven alternative to other legally marketed topical skin adhesives. The TissueSeal management team has been serving the medical device industry collectively for over 85 years.
Source: B. Braun Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!